𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serologic response in human papillomavirus-associated invasive cervical cancer

✍ Scribed by Raphael P. Viscidi; Yeping Sun; Brian Tsuzaki; F. Xavier Bosch; Nubia Munoz; Keerti V. Shah

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
585 KB
Volume
55
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Human papillomavirus (HPV) transforming proteins E6 and E7 are uniformly expressed in HPV‐associated cervical cancer. Our objective was to measure antibodies to HPV‐16 E6 and E7 proteins in cervical cancer patients using an assay which would detect antibodies to conformational epitopes. Serum specimens obtained from two case‐control studies of HPVs and cervical cancer were tested. The studies were performed in Cali, Colombia, South America and in 9 provinces of Spain. Cases consisted of women with invasive cervical cancer associated with HPV‐16 or other HPV types and women with HPV‐16‐associated high‐grade cervical intra‐epithelial neoplasia (CIN‐3). Controls for invasive cases and CIN‐3 cases were women who had no cytologic abnormalities and who were matched for age and country of residence. Serum antibodies to HPV‐16 E6 and E7 proteins were detected by radio‐immunoprecipitation of in vitro translated proteins. Antibodies to the E6 and E7 protein were observed among 56% and 43%, respectively, of invasive cases and 1.7% and 4.1%, respectively, of controls. Antibodies to either protein were detected in 72% of sera from invasive cases and 5.8% of sera from controls. High antibody reactivity and antibodies to both proteins were found almost exclusively in invasive cases. The frequency of antibodies to the E6 protein and the E7 protein among CIN‐3 cases did not differ significantly from the CIN‐3 controls. Five women with HPV‐18‐associated invasive cervical cancer were negative for serum antibody to HPV‐16 E6 and E7 proteins. Antibodies to HPV‐16 E6 and E7 proteins appear to be partially virus‐specific and disease state‐specific markers of HPV‐associated cervical cancer.

📜 SIMILAR VOLUMES

Human papillomavirus infection and invas
Human papillomavirus infection and invasive cervical cancer in Paraguay
✍ Pedro A. Rolón; Jennifer S. Smith; Nubia Muñoz; Stefanie J. Klug; Rolando Herrer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 63 KB 👁 2 views

HPV types 16 and 18 have been categorized as human carcinogens based on their strong associations with cervical cancer in previous case-control studies. Recent IARC studies in the Philippines, Thailand and Morocco show strong associations between invasive cervical cancer and less common HPV types, i

Distribution of human papillomavirus gen
Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada
✍ François Coutlée; Samuel Ratnam; Agnihotram V. Ramanakumar; Ralph R. Insinga; Ja 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract Infection with high‐risk human papillomavirus (HPV) causes cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC). The distribution of HPV types in cervical diseases has been previously described in small studies for Canadian women. The prevalence of 36 HPV genotype

Human papillomavirus infection, cervical
Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: A case-control study
✍ Annabelle Ferrera; Johan P. Velema; Manuel Figueroa; Ricardo Bulnes; Luis A. Tor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 47 KB 👁 3 views

A substantial body of evidence has confirmed human papillomavirus (HPV) infection as the central etiological agent in human cervical carcinogenesis. In Honduras, cervical cancer is the most common cancer among women, with a high annual incidence. We conducted a population-based, case-control study o